TrialJournal of clinical immunology2003

Pilot study of an HLA-A2 peptide vaccine using flt3 ligand as a systemic vaccine adjuvant.

Douglas G McNeel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.